Specify a stock or a cryptocurrency in the search bar to get a summary
bioAffinity Technologies, Inc.
BIAFbioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas. Address: 22211 West Interstate 10, San Antonio, TX, United States, 78257
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BIAF
Dividend Analytics BIAF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIAF
Stock Valuation BIAF
Financials BIAF
Results | 2019 | Dynamics |